Clinical trials
Completed Cardiomyopathies trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
255 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 6 |
| 2002 | 4 |
| 2003 | 4 |
| 2004 | 9 |
| 2005 | 8 |
| 2006 | 10 |
| 2007 | 9 |
| 2008 | 9 |
| 2009 | 9 |
| 2010 | 13 |
| 2011 | 9 |
| 2012 | 12 |
| 2013 | 9 |
| 2014 | 24 |
| 2015 | 12 |
| 2016 | 19 |
| 2017 | 9 |
| 2018 | 9 |
| 2019 | 6 |
| 2020 | 18 |
| 2021 | 10 |
| 2022 | 12 |
| 2023 | 8 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 255 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Heart, Lung, and Blood Institute (NHLBI) | 12 |
| Abbott Medical Devices | 8 |
| Mayo Clinic | 7 |
| Scios, Inc. | 5 |
| Washington University School of Medicine | 5 |
| Alnylam Pharmaceuticals | 4 |
| Duke University | 4 |
| Emory University | 4 |
| Medtronic Cardiac Rhythm and Heart Failure | 4 |
| Pfizer | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardiomyopathies | 255 |
| Heart Failure | 90 |
| Heart Diseases | 27 |
| Cardiovascular Diseases | 23 |
| Amyloidosis | 13 |
| Ventricular Dysfunction | 12 |
| Arrhythmias, Cardiac | 10 |
| Coronary Artery Disease | 10 |
| Death, Sudden, Cardiac | 9 |
| Heart Defects, Congenital | 9 |
Trials
Showing 51 to 75 of 255. Each trial links to its page on Pharma Observatory.
155 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.